Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuronetics (STIM) EBT Margin (2017 - 2025)

Neuronetics (STIM) has disclosed EBT Margin for 9 consecutive years, with 17.62% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 4399.0% to 17.62% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 26.47% through Dec 2025, up 2972.0% year-over-year, with the annual reading at 26.72% for FY2025, 2916.0% up from the prior year.
  • EBT Margin for Q4 2025 was 17.62% at Neuronetics, up from 24.99% in the prior quarter.
  • The five-year high for EBT Margin was 17.62% in Q4 2025, with the low at 78.37% in Q1 2022.
  • Average EBT Margin over 5 years is 50.42%, with a median of 51.24% recorded in 2021.
  • The sharpest move saw EBT Margin plummeted -3195bps in 2021, then soared 4399bps in 2025.
  • Over 5 years, EBT Margin stood at 53.08% in 2021, then increased by 9bps to 48.51% in 2022, then surged by 36bps to 30.87% in 2023, then crashed by -100bps to 61.61% in 2024, then skyrocketed by 71bps to 17.62% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 17.62%, 24.99%, and 25.87% for Q4 2025, Q3 2025, and Q2 2025 respectively.